What does compensation for neurologists look like these days? Would you choose neurology all over again?
NeurologyLive® Friday 5 — May 17, 2024
Episode 115: Expanding Access to Ublituximab and AntiCD20s for Multiple Sclerosis
Dosing Commenced for Phase 1a Study of Anti-Tau Antibody VY-TAU01 in Alzheimer Disease
Episode 114: AMX0035, Phase 3 PHOENIX Study, and Amylyx's Future Drug Development
Anti-NMDA Receptor Encephalitis Disproportionately Impacts Black, Hispanic, and Asian Populations, Study Shows
FDA Grants Rare Pediatric Disease Designation to DMD Gene Therapy Candidate SGT-003